Loading resource…

World Health Organization
The document provides specific treatment protocols for managing drug-resistant leprosy in adults, focusing on combination therapies tailored to various resistance scenarios. It includes detailed dosage information and duration of treatment for each regimen. The guidelines are based on recommendations from the World Health Organization and aim to standardize care for affected individuals.
No account needed
Adult Drug-Resistant Leprosy: Levofloxacin 500 mg Assumes Normal Kidney Function
“Alternatives to ofloxacin include levofloxacin (500 mg orally once daily for patients with normal kidney function) or moxifloxacin (400 mg orally once daily).”